Literature DB >> 29044738

Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective.

Dinesh Subedi1, Ajay Kumar Vijay1, Mark Willcox1.   

Abstract

Treatment of Pseudomonas aeruginosa eye infections often becomes a challenge due to the ability of this bacterium to be resistant to antibiotics via intrinsic and acquired mechanisms. Transfer of resistance due to interchangeable genetic elements is an important mechanism for the rapid transfer of antibiotic resistance in this pathogen. As a result, drug-resistant strains are becoming increasingly prevalent worldwide. This review systematically analyses data from recent publications to describe the global prevalence and antibiotic sensitivity of ocular P. aeruginosa. Thirty-seven studies were selected for review from PubMed-based searches using the criteria 'microbial keratitis OR eye infection AND Pseudomonas aeruginosa AND antibiotic resistance' and limiting to papers from 2011 onward, to demonstrate the antibiotic resistance from isolates from around the world. Subsequently, we reviewed the ways in which P. aeruginosa can become resistant to antibiotics. Both the rate of isolation of bacteria in general (79 per cent of cases), and prevalence of P. aeruginosa (68 per cent of all isolates) were highest in contact lens-related microbial keratitis. The average resistance rate to common ocular antibiotics such as ciprofloxacin (9 per cent), gentamicin (22 per cent) and ceftazidime (13 per cent) remained relatively low. However, there were large variations in resistance rates reported in studies from different countries, for example resistance to ciprofloxacin reached up to 33 per cent. We next reviewed the types of mobile genetic elements (MGEs) such as plasmids, integrons and transposons that are frequently associated with drug resistance in P. aeruginosa. MGEs are important for the transmission of resistance to beta-lactams and aminoglycosides and recently have been shown to be potential factors for the transmission of fluoroquinolone resistance. Studies on the molecular mechanisms of resistance transfer in ocular P. aeruginosa have begun to be reported and will provide valuable information on the emergence of new antibiotic resistance and potential to treat resistant strains.
© 2017 Optometry Australia.

Entities:  

Keywords:  Pseudomonas aeruginosa; antibiotic resistance; keratitis

Mesh:

Year:  2017        PMID: 29044738     DOI: 10.1111/cxo.12621

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  27 in total

1.  Cationic polymer contributes to broaden the spectrum of vancomycin activity achieving eradication of Pseudomonas aeruginosa.

Authors:  Melisa B Corti; Luciana P Campagno; Verónica L Romero; Silvina Gutierrez; Fabiana L Alovero
Journal:  Arch Microbiol       Date:  2022-07-20       Impact factor: 2.667

Review 2.  Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics.

Authors:  Shugang Qin; Wen Xiao; Chuanmin Zhou; Qinqin Pu; Xin Deng; Lefu Lan; Haihua Liang; Xiangrong Song; Min Wu
Journal:  Signal Transduct Target Ther       Date:  2022-06-25

3.  Characterization and genome analysis of Pseudomonas aeruginosa phage vB_PaeP_Lx18 and the antibacterial activity of its lysozyme.

Authors:  Yin Yin; Xinwei Wang; Zehua Mou; Huiying Ren; Can Zhang; Ling Zou; Huanqi Liu; Wenhua Liu; Zongzhu Liu
Journal:  Arch Virol       Date:  2022-06-18       Impact factor: 2.685

4.  Povidone Iodine 0.66% to Fight Pseudomonas aeruginosa in Contact Lens Wearer: A Case Report.

Authors:  Stefano Castelnuovo
Journal:  Case Rep Ophthalmol       Date:  2022-05-31

5.  Comparison of Ceftolozane/Tazobactam Infusion Regimens in a Hollow-Fiber Infection Model against Extensively Drug-Resistant Pseudomonas aeruginosa Isolates.

Authors:  María Milagro Montero; Sandra Domene-Ochoa; Carla López-Causapé; Inmaculada López-Montesinos; Sonia Luque; Luisa Sorlí; Núria Campillo; Eduardo Padilla; Núria Prim; Lorena Ferrer Alapont; Santiago Grau; Antonio Oliver; Juan P Horcajada
Journal:  Microbiol Spectr       Date:  2022-06-13

6.  Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.

Authors:  María Montero; Sandra Domene Ochoa; Carla López-Causapé; Brian VanScoy; Sonia Luque; Luisa Sorlí; Núria Campillo; Ariadna Angulo-Brunet; Eduardo Padilla; Núria Prim; Virginia Pomar; Alba Rivera; Santiago Grau; Paul G Ambrose; Antonio Oliver; Juan P Horcajada
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  Genomic characterization of Escherichia coli LCT-EC001, an extremely multidrug-resistant strain with an amazing number of resistance genes.

Authors:  Xuelin Zhang; Saisong Xiao; Xuege Jiang; Yun Li; Zhongyi Fan; Yi Yu; Peng Wang; Diangeng Li; Xian Zhao; Changting Liu
Journal:  Gut Pathog       Date:  2019-05-21       Impact factor: 4.181

8.  Study of Disinfectant Resistance Genes in Ocular Isolates of Pseudomonas aeruginosa.

Authors:  Dinesh Subedi; Ajay Kumar Vijay; Mark Willcox
Journal:  Antibiotics (Basel)       Date:  2018-10-15

9.  Formulation of Ocular In Situ Gels with Lithuanian Royal Jelly and Their Biopharmaceutical Evaluation In Vitro.

Authors:  Kristina Perminaite; Mindaugas Marksa; Monika Stančiauskaitė; Tadas Juknius; Aidas Grigonis; Kristina Ramanauskiene
Journal:  Molecules       Date:  2021-06-10       Impact factor: 4.411

Review 10.  Multidrug Resistance (MDR) and Collateral Sensitivity in Bacteria, with Special Attention to Genetic and Evolutionary Aspects and to the Perspectives of Antimicrobial Peptides-A Review.

Authors:  András Fodor; Birhan Addisie Abate; Péter Deák; László Fodor; Ervin Gyenge; Michael G Klein; Zsuzsanna Koncz; Josephat Muvevi; László Ötvös; Gyöngyi Székely; Dávid Vozik; László Makrai
Journal:  Pathogens       Date:  2020-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.